May 14, 2025PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.25.

Chemomab Therapeutics Ltd.(Nasdaq:CMMB), (Chemomab), a clinical-stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced ...

Despite protests about the tower, the Transamerica Pyramid was built in 3 years. Fast-forward 50 years, and a lot has changed ...

Greetings and welcome to the PDS Biotech first quarter in 2025 earnings conference call. (operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce ...

Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet ...

Schrödinger, Inc. today announced that initial Phase 1 clinical data for SGR-1505, its investigational MALT1 inhibitor, will be presented at the European Hematology Association Annual Congress, taking ...

Codexis reiterated its full-year 2025 financial guidance originally issued on February 27, 2025, as follows: Total revenues are expected to be in the range of $64 million to $68 million.

Young entrepreneurs are invited to turn lemons into sweet rewards July 19. The Dickinson Area Chamber of Commerce has kicked ...

DAHON, a global leader in the folding bike industry, showcased its vision for the future of cycling at China Cycle 2025, featuring award-winning innovations and the cutting-edge DAHON-V technology.

As the iconic firm prepares for a new chapter, let's take a look at some of its highs and lows over the years.

Shara capped a remarkable turnabout for the leader of the rebel uprising that ousted Bashar al-Assad. Mr. Trump has said he ...

The type of drag motherhood showcased internationally by Ru Paul’s Drag Race is the most satisfying of serotonin rushes. What ...